Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4955)
All Articles published online
|
Publishing Process of This Article
|
Jan 27, 2021 (publication date) through Jan 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tarao K, Nozaki A, Chuma M, Taguri M, Maeda S. Effectiveness of entecavir in preventing hepatocellular carcinoma development is genotype-dependent in hepatitis B virus-associated liver cirrhosis. World J Hepatol 2021; 13(1): 144-150 [PMID: 33584993 DOI: 10.4254/wjh.v13.i1.144] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v13/i1/144.htm |
| Number | Citing Articles |
| 1 |
Baofang Zhang, Lei Yu, Mingliang Cheng, Quan Zhang, Jun Wu, Jing Yang, Qin Liu, Shuang Lu, Xueke Zhao, KaiSheng Deng, Yongmei Liu, Jun Wang, Peiling Zhao. Hepatitis B virus genotype is an independent prognostic factor of telbivudine and tenofovir treatment in hepatitis B surface antigen‐positive pregnant women. Food Science & Nutrition 2022; 10(1): 3 doi: 10.1002/fsn3.2619
|